top of page
Search Results

43 items found for "Richard J. Law"

Posts (18)

  • Exscientia welcomes Richard J. Law, as their new Chief Business Officer

    March 2022 "Congratulations to Richard J. Law, our newly named Chief Business Officer. Richard is the architect behind nearly all of Exscientia's partnerships and collaborations across pharma

  • Dr. Nicola J. Smith - Dr. GPCR Podcast

    Next on the Dr. GPCR Podcast, we have Dr. Nicola Smith, Molecular Pharmacologist, lab head, and senior lecturer at UNSW Sydney. Subscribe to the podcast today and get notified when new episodes are released! Please share! https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #gpcr #drgpcr #podcast

  • Nanobodies: New Dimensions in GPCR Signaling Research

    J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., Devree, B. T., Rosenbaum, D. M., Thian, F. H., Pautsch, A., Steyaert, J., Weis, W. I., & Kobilka, B. K. (2011). M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. C., Gmeiner, P., Steyaert, J., Weis, W. I., Garcia, K. C., Wess, J., & Kobilka, B. K. (2013). Nature, 504(7478), 101–106. https://doi.org/10.1038/nature12735 Burg, J. S., Ingram, J.

View All

Other Pages (25)

  • Ep 132 with Dr. Richard Premont

    Richard Premont About Dr. Richard Premont "Dr. Richard Premont on the web Google Scholar LinkedIn Dr.

  • Ep 131 with Dr. Richard Premont

    Richard Premont About Dr. Richard Premont "Dr. Richard Premont on the web Google Scholar LinkedIn Dr.

  • 22-03 Dr GPCR Newsletter

    Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology Exscientia welcomes Richard J. Law, as their new Chief Business Officer Confo Therapeutics Doses First Subjects In Phase 1 Clinical

View All